Simpson C W, Plunkett E R
Fertil Steril. 1979 Nov;32(5):510-7.
Fifteen patients, age 16 to 55, presented with amenorrhea-galactorrhea-hyperprolactinemia. Pituitary function was evaluated by bolus injections of insulin, luteinizing hormone-releasing hormone (LHRH), and thyrotropin-releasing hormone (TRH) in 13 and by LHRH and TRH in 2. Responses to growth hormone (GH), thyroid-stimulating hormone (TSH), cortisol (F), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin were measured. GH, TSH, and F responses were normal in most cases. LH responses were decreased (P less than 0.025) in patients with abnormal sellar tomography, whereas FSH responses tended to decrease with elevated prolactin levels. Prolactin responses were absent in five of the seven cases which could be evaluated. The clinical value of such testing appears to be limited to an individualized basis, although some prognosis of ovulatory response to bromocriptine therapy may be obtained from the gonadotropin response.
15名年龄在16至55岁之间的患者出现闭经、溢乳和高泌乳素血症。13名患者通过静脉注射胰岛素、促黄体生成素释放激素(LHRH)和促甲状腺激素释放激素(TRH)评估垂体功能,2名患者通过LHRH和TRH评估。测量了对生长激素(GH)、促甲状腺激素(TSH)、皮质醇(F)、促黄体生成素(LH)、促卵泡生成素(FSH)和泌乳素的反应。大多数情况下,GH、TSH和F反应正常。蝶鞍断层扫描异常的患者中,LH反应降低(P<0.025),而FSH反应倾向于随着泌乳素水平升高而降低。在可评估的7例患者中,有5例无泌乳素反应。尽管从促性腺激素反应中可能获得一些对溴隐亭治疗排卵反应的预后信息,但这种检测的临床价值似乎仅限于个体化情况。